Mirum Prescribed drugs to Host Investor Name to Share Interim Evaluation Outcomes from the Volixibat VANTAGE and VISTAS research on June 17, 2024
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Prescribed drugs, Inc. (NASDAQ: MIRM) at this time…
By
admin